CRISPR Therapeutics AG
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/3/2026 | 246 | 0.0% | 4,576 | 12/31/2025 |
| 2025 Q3 | 11/12/2025 | 396 | 0.0% | 6,103 | 9/30/2025 |
| 2025 Q2 | 8/7/2025 | 296 | 0.0% | 6,091 | 6/30/2025 |
| 2025 Q1 | 5/12/2025 | 195 | 0.0% | 5,725 | 3/31/2025 |
| 2024 Q4 | 2/12/2025 | 215 | 0.0% | 5,252 | 12/31/2024 |
| 2024 Q3 | 11/8/2024 | 229 | 0.0% | 4,880 | 9/30/2024 |
| 2024 Q2 | 8/13/2024 | 288 | 0.0% | 5,334 | 6/30/2024 |
| 2024 Q1 | 5/9/2024 | 227 | 0.0% | 3,332 | 3/31/2024 |
| 2023 Q4 | 2/8/2024 | 218 | 0.0% | 3,481 | 12/31/2023 |
| 2023 Q3 | 11/7/2023 | 204 | 0.0% | 4,484 | 9/30/2023 |
| 2023 Q2 | 8/9/2023 | 247 | 0.0% | 4,408 | 6/30/2023 |
| 2023 Q1 | 5/8/2023 | 212 | 0.0% | 4,680 | 3/31/2023 |
| 2022 Q4 | 2/7/2023 | 178 | 0.0% | 4,353 | 12/31/2022 |
| 2022 Q3 | 11/1/2022 | 292 | 0.0% | 4,464 | 9/30/2022 |
| 2022 Q2 | 8/4/2022 | 266 | 0.0% | 4,376 | 6/30/2022 |
| 2022 Q1 | 5/9/2022 | 236 | 0.0% | 3,767 | 3/31/2022 |
| 2021 Q4 | 2/7/2022 | 275 | 0.0% | 3,467 | 12/31/2021 |
| 2021 Q3 | 11/4/2021 | 313 | 0.0% | 2,799 | 9/30/2021 |
| 2021 Q2 | 8/6/2021 | 453 | 0.0% | 2,799 | 6/30/2021 |
| 2021 Q1 | 5/6/2021 | 401 | 0.0% | 3,294 | 3/31/2021 |
| 2020 Q4 | 2/9/2021 | 345 | 0.0% | 2,256 | 12/31/2020 |
| 2020 Q3 | 11/10/2020 | 250 | 0.0% | 2,985 | 9/30/2020 |
| 2020 Q2 | 8/6/2020 | 220 | 0.0% | 2,999 | 6/30/2020 |
| 2020 Q1 | 5/11/2020 | 111 | 0.0% | 2,610 | 3/31/2020 |
| 2019 Q4 | 2/5/2020 | 120 | 0.0% | 2,013 | 12/31/2019 |